ChartMill assigns a Buy % Consensus number of 83% to ARMP. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-17 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-07 | HC Wainwright & Co. | Reiterate | Buy |
| 2021-03-22 | HC Wainwright & Co. | Maintains | Buy |
7 analysts have analysed ARMP and the average price target is 9.18 USD. This implies a price increase of 55.59% is expected in the next year compared to the current price of 5.9.
The consensus rating for ARMATA PHARMACEUTICALS INC (ARMP) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.